Profitability
Weight: 25%
D-
30
- 5yr Avg ROIC -6.6%
- Operating Margin Trend +11.61 pp/yr
CSTL
Castle Biosciences, Inc.
AlphaQuality composite grade, weighted for platform & compounding fcf businesses.
⚠ 4 of the last 5 fiscal years showed negative net income — AlphaQuality will not grade above F for persistent unprofitability in a platform & compounding fcf business.
Grade overrides the 30.0 pillar composite — hard gates always win.
Capital Efficiency
Weight: 15%
F
0
- 5yr Avg ROE -8.0%
- 5yr Share-Count CAGR 8.9%
Growth Quality
Weight: 25%
A+
100
- 5yr Revenue CAGR 40.6%
- Revenue-Growth Years (5) 5/5
Cash Generation
Weight: 20%
D
36
- 5yr FCF Margin -9.6%
- 5yr FCF/NI Conversion 2.00x
Balance Sheet
Weight: 10%
B
70
- Net Debt / EBITDA -23.15x
- Interest Coverage (EBIT/Int) -342.19x
- Altman Z-Score 5.99
Stability
Weight: 5%
B
70
- Negative-Revenue Years (5) 0/5
- Piotroski F-Score 4
Guru Flow
Curated superinvestor sentiment — not part of the AlphaQuality grade.2 of 2 gurus held; 1 added; 1 trimmed.
- Holders
- 2 +1
- Avg Δ position
- -46.8%
- New buys
- 0
- Full exits
- 0